Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

GlobeNewswire

NEW YORK, Nov. 04, 2026 -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it hosted a key opinion leader webinar this week titled “The Graft-versus-Host Disease Exchange - Expert Perspectives on Evolving Clinical Practice” with leading pediatric transplant and cellular-therapy specialist Dr. Susan Prockop, Associate Professor, Harvard Medical School; Attending Physician & Director, Boston Children's Hospital. Dr. Prockop provided an overview of Ryoncil® (remestemcel-L-rknd)1 as a new treatment paradigm in the management of acute graft-versus-host disease, its use as first line after steroids, highlighted case studies, and discussed results from pivotal trials.

  1. FinanceROSEN, A LEADING LAW FIRM, Encourages Coastal Financial Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CCBWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Coastal Financial Corporation (NASDAQ: CCB) between October 28, 2024 and July 29, 2026, inclusive (the “Class Period”), of the important December 1, 2026 lead plaintiff deadline.
  2. FinanceLKQ Investor News: If You Have Suffered Losses in LKQ Corporation, You Are Encouraged to Contact The Rosen Law Firm About Your RightsWHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LKQ Corporation (NASDAQ: LKQ) resulting from allegations that LKQ Corporation may have issued materially misleading business information to the investing public.
  3. FinanceHeartland Express, Inc.Heartland Express, Inc. Announces Participation in Upcoming ConferenceHeartland Express, Inc. (Nasdaq: HTLD) announced that Chris Strain, Chief Financial Officer, will present and participate at Baird’s 2026 Global Industrial Conference on Thursday, November 12, 2026.
  4. FinanceROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ENSGWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Ensign Group, Inc. (NASDAQ: ENSG) between February 10, 2022 and June 18, 2026, both dates inclusive (the “Class Period”), of the important December 7, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
  5. AIMedVirtual Highlights the Human Advantage in Healthcare Staffing Amid the Rise of AI AlternativesAs AI receptionists, chatbots, and automated assistants are marketed to healthcare practices as staffing replacements, MedVirtual says the skills patients and providers rely on most are still human ones
  6. AutomotivePolypropylene Market Size to Reach 139.2 Million Tons by 2032 as Asia-Pacific Packaging and Homopolymer Demand Surge, Reports Mordor IntelligenceThe polypropylene market is gaining momentum through rising demand for lightweight automotive components, wider adoption of mono-material flexible packaging, and expanding use of high-melt-strength PP in foamed applications, while chemical-recycling partnerships are creating opportunities for recycled-content polypropylene across packaging and industrial applications.